To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
DRI to seek $1bn for third fund
The Toronto-based firm, which focuses on pharmaceutical royalties, has been busy since closing its second fund on $701m in 2010.
